Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
about
Enoxaparin in acute coronary syndromesHeparin in interventional radiology: a therapy in evolutionSafety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registryOptimizing adjunctive antithrombotic therapy in the treatment of acute myocardial infarction: a role for low-molecular-weight heparin.Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis.Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.Utilizing enoxaparin in the management of STEMI.New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implicationsEfficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial Infarction.Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.Safety evaluation of enoxaparin in currently approved indications.Cost effectiveness of anticoagulation in acute coronary syndromes.Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus.Anti-Xa activity of enoxaparin and nadroparin in patients with acute coronary syndrome.Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis.ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
P2860
Q28301431-E716A1E3-70DC-41BE-8D53-384B6E4D8840Q33394179-3F3A0A9A-A9B5-4742-B50E-D3FBDCF338B5Q34196711-5E3C4B2A-0F33-44CE-99BB-8029332B64D1Q35638777-A99A6CAA-4B64-4989-9B15-9FFAB2FC77C0Q36035257-EB121DD9-7FD1-4CB9-A724-D99E7F847FC9Q36131116-E38E7FB1-F955-46B0-B55C-AE2211BE76F4Q36545687-9BA9B068-AAFD-4279-BFC1-243E630117AEQ37031371-8DD2CB94-5824-48BD-B65C-D360529355D5Q37193906-C6F16C5B-05A4-4E63-9CCC-62E8C14949BBQ37414802-6269E099-6259-4069-9219-B195DE57AA43Q37445888-E366CF39-8B33-4053-B120-1B1F374706EEQ37622250-5E328B6B-C0AB-4FE5-A3D1-191585F8B2F1Q37992680-C1BE5ABE-5FB4-41C9-825B-F0B1105CB211Q37997963-2E9E6D5A-36DF-4517-AEB1-111FF07BA120Q41807158-C2F1F8EA-7E34-4965-A11F-31EE8A0CC8BEQ47365108-617EAE70-027D-4305-BF91-036D07E196B7Q50665407-F9A5D531-9699-4697-ABDD-93CA58BF9B5A
P2860
Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Randomized comparison of enoxa ...... r acute myocardial infarction.
@en
Randomized comparison of enoxa ...... r acute myocardial infarction.
@nl
type
label
Randomized comparison of enoxa ...... r acute myocardial infarction.
@en
Randomized comparison of enoxa ...... r acute myocardial infarction.
@nl
prefLabel
Randomized comparison of enoxa ...... r acute myocardial infarction.
@en
Randomized comparison of enoxa ...... r acute myocardial infarction.
@nl
P2093
P356
P1476
Randomized comparison of enoxa ...... r acute myocardial infarction.
@en
P2093
P304
P356
10.1053/EUHJ.2001.2940
P577
2002-04-01T00:00:00Z